pulmonary fibrosis

(Northwestern University) A drug used to treat cancer may also be effective in diseases that cause scarring of the internal organs or skin, such as pulmonary fibrosis or scleroderma.

The drug, with the generic name bortezomib, stopped the development of fibrotic proteins in human cells and stopped the development of fibrous scarring in a mouse model of fibrotic disease.

There currently is no effective treatment for these diseases, which have a high fatality rate.

Share:

From today's New York Times comes word of an unusual legal case,

In a verdict that could strike fear into pharmaceutical industry executive suites, the former head of a drug company was convicted of wire fraud Tuesday for issuing what federal prosecutors called a misleading press release that contributed to off-label sales of his company’s drug.

SAN DIEGO (MedPage Today) -- The investigational antifibrotic agent pirfenidone slows progression of idiopathic pulmonary fibrosis, a large, randomized trial showed.

TORONTO -- An investigational anti-fibrotic agent is showing promise in the treatment of idiopathic pulmonary fibrosis (IPF), a researcher said here.